Bahman Bashardoust, Roya Alaei, Sousan Mohammadi Kebar, Sabah Hasani, & Afshin Habibzadeh. (2018). The effect of oral N-acetylcysteine on serum high sensitive CRP and plasma hemoglobin levels in end-stage renal disease patients under routine hemodialysis; a randomized placebocontrolled clinical trial. Society of Diabetic Nephropathy Prevention.
Chicago Style (17th ed.) CitationBahman Bashardoust, Roya Alaei, Sousan Mohammadi Kebar, Sabah Hasani, and Afshin Habibzadeh. The Effect of Oral N-acetylcysteine on Serum High Sensitive CRP and Plasma Hemoglobin Levels in End-stage Renal Disease Patients Under Routine Hemodialysis; a Randomized Placebocontrolled Clinical Trial. Society of Diabetic Nephropathy Prevention, 2018.
MLA (9th ed.) CitationBahman Bashardoust, et al. The Effect of Oral N-acetylcysteine on Serum High Sensitive CRP and Plasma Hemoglobin Levels in End-stage Renal Disease Patients Under Routine Hemodialysis; a Randomized Placebocontrolled Clinical Trial. Society of Diabetic Nephropathy Prevention, 2018.